Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
05/2009
05/27/2009CN100490832C Method for preparing kidney-warming face-nourishing liquor containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc.
05/27/2009CN100490677C Nutritious tablet for female
05/26/2009US7538121 Vanilloid receptor modulators
05/26/2009US7538118 6-aminomorphinane derivatives, method for production and use thereof
05/26/2009US7538100 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
05/26/2009US7538099 Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses
05/26/2009US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds
05/26/2009CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
05/26/2009CA2454675C 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
05/26/2009CA2436668C Novel succinate salt of o-desmethyl-venlafaxine
05/26/2009CA2387201C Tetrahydroquinoline derivatives
05/26/2009CA2295512C Prostaglandin product
05/26/2009CA2242879C Method for treating sexual dysfunctions
05/22/2009WO2009063993A1 Fused pyridine derivative and use thereof
05/22/2009WO2009063991A1 Pyridooxazepine derivative and use thereof
05/22/2009WO2009063365A1 Azetidines as ep2 antagonists
05/22/2009WO2009062910A1 Composition for moderating triglyceride and cholesterol levels
05/22/2009WO2009062683A1 C-19 steroids for therapeutic uses
05/22/2009WO2009062402A1 Quinazolinone derivatives, the preparation methods and uses thereof
05/22/2009WO2009062338A1 A lactogenic chinese medicine for treatment and prevention of gynecopathy, methods of preparation and uses thereof
05/22/2009CA2705368A1 Azetidines as ep2 antagonists
05/21/2009US20090131465 Synthesis and crystalline forms of melanocortin-4 receptor agonist
05/21/2009US20090131404 Combinations
05/21/2009US20090131387 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
05/21/2009US20090130126 Dna expression vectors
05/20/2009EP2060621A1 Wheat-germ oil concentrate, a method for the production thereof, a method for producing wheat-germ oil and a medicinal and prophylactic composition based thereon and used for treating sexual dysfunctions
05/20/2009EP2060300A1 C-19 steroids for therapeutic uses
05/20/2009EP2059802A2 Methods for designing parp inhibitors and uses thereof
05/20/2009EP2059248A1 Pharmaceutical preparation for the alleviation of endometriosis
05/20/2009EP1888058B1 Inhibitors of soluble adenylate cyclase
05/20/2009EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
05/20/2009EP1208113B1 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties
05/20/2009CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101433724A Use of Akt2-siRNA fusion expression vector in preparing medicament for inhibiting metastasis of human breast cancer cell
05/20/2009CN101433714A Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
05/20/2009CN101433706A Method for preparing decoction for invigorating spleen
05/20/2009CN101433700A Medicament for treating climacteric syndrome and preparation method thereof
05/20/2009CN101433668A Prescription of wine for beauty treatment and face nursing and production method
05/20/2009CN101433656A Vaginitis treating medicine
05/20/2009CN101433654A Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof
05/20/2009CN101433650A Chinese medicinal composition for treating intermenstrual flow and dysmenorrhea
05/20/2009CN101433623A Capsule for health preserving of female and nursing face and preparation method thereof
05/20/2009CN101433611A Method for making wine for strengthening force
05/20/2009CN101433602A Process for preparing wine for mainly treating intolerance of cold, anemia and gynecopathy
05/20/2009CN101433585A Use of pharmaceutical composition in preparing medicament for preventing and treating gynaecologic disease
05/20/2009CN101433568A Extraction of burdock root aqueous extract and use
05/20/2009CN100488525C Medicine for treating female climacterium syndrome and its preparation method
05/20/2009CN100488517C Composition for trapping and inactivating pathogenic microbes and spermatozoa and its pharmaceutical uses
05/20/2009CN100488510C Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
05/20/2009CN100488509C Sildenafil citrate sublingual tablet and its preparation method
05/19/2009US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia
05/19/2009US7534441 Immunogenic LHRH compositions and methods relating thereto
05/19/2009CA2382580C Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
05/19/2009CA2230931C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
05/14/2009WO2009062034A1 Methods, compositions, and sequences of zp-binding peptides for immunocontraception of dogs and other animals
05/14/2009WO2009060609A1 Method for producing microcapsule using solid fat
05/14/2009WO2009059961A2 A method of hormone suppression in humans
05/14/2009WO2009059765A2 Process for the preparation of drospirenone
05/14/2009WO2009059690A1 Use of a gestagen in combination with an estrogen and one or more pharmaceutically tolerable excipients/carriers for lactose-free oral contraceptive
05/14/2009WO2009042127A3 Compositions and methods for rescuing fertility
05/14/2009WO2009016350A3 Stimulating gel
05/14/2009WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use
05/14/2009US20090124590 Pharmaceutical composition
05/14/2009US20090124589 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism
05/14/2009US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases
05/14/2009US20090124537 Screening method for bone morphogenetic mimetics
05/14/2009US20090123571 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
05/14/2009US20090123534 comprising progesterone, soy bean lecithin, and olive oil, wherein at least about 80% of the particles of progesterone are characterized by a particle size of between 1 and 15 mu m; for treating a physiological condition linked to insufficiency of progesterone secretion
05/14/2009US20090123522 Medicament Delivery Device and a Method of Medicament Delivery
05/14/2009US20090123503 Conditioned Cell Culture Medium Compositions and Methods of Use
05/14/2009US20090123433 Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation
05/14/2009CA2704523A1 Use of a gestagen in combination with an estrogen and one or more pharmaceutically tolerable excipients/carriers for lactose-free oral contraceptive
05/14/2009CA2703497A1 A method of hormone suppression in humans
05/13/2009EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative
05/13/2009EP2058305A1 Urea derivative
05/13/2009EP2057905A1 Composition for moderating Triglyceride and Cholesterol Levels
05/13/2009EP1655028B1 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems
05/13/2009CN101429166A Quinazoline ketone derivant, preparation method and application thereof
05/13/2009CN101428140A Sustained-release incretion particle for inducing maturation of Oplegnathus fasciatus gonad and preparation method thereof
05/13/2009CN101428139A Method for extending spermiation period of verasper moseri
05/13/2009CN101428106A Medicament composition for treating female acyesis and aphoria, and uses thereof
05/13/2009CN101428041A Cordyceps sinensis extract, preparation method and uses in preparing medicament
05/13/2009CN101427993A Prostaglandin microemulsion gel rubber preparation and method of producing the same
05/13/2009CN101427983A Female washing and protecting condensation with sterilizing effect and method of producing the same
05/13/2009CN100486995C Compositions and methods for WT1 specific immunotherapy
05/13/2009CN100486967C 5HT2C receptor modulators
05/13/2009CN100486618C Medicine for treating gynecologic menstrual irregularities and difficult menstruation and production thereof
05/13/2009CN100486581C Progesterone membrane agent and its preparing method
05/13/2009CN100486576C Substituted pyridinones as modulators of P38MAP kinase
05/13/2009CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use
05/13/2009CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth
05/13/2009CN100486471C Magnetic beads activity factor cream massage bra
05/13/2009CN100486426C Method for constructing allotetraploid of bluntsnout bream
05/12/2009US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation
05/12/2009US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure
05/12/2009US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
05/12/2009US7531571 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction
05/12/2009US7531564 Substituted benzoxazoles as estrogenic agents